u/ismael_eriksen

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

the weight curves are unusually steep, which makes predicting individual response harder

A1c moves slowly, quarterly is plenty

Crossposting this to c/semaglutide because the people who need it are not reading this community.

Disagree on that part. 98.1% and 98.4% on the same vial is normal.

receptor distribution matters, GLP-1 is not everywhere

I am going to push back on this slightly.

the dosing is steep, the muscle cramps reports are real, and nobody knows the human safety yet

This is correct. ApoB is the better marker.

redact identifying details from lab PDFs before posting

My A1c went from 18 to 40 in 50 weeks. The baseline labs story shows up in the trend, not the single number.

do not editorialise in the title, put the number in the title and the opinion in the body

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

no "is this good?" without saying what the compound and claimed purity are

The confident tone is doing a lot of work that the evidence is not.

Yeah, baseline matters more than any later number.

redact your own name, not the vendor's batch details

baseline is the most important lipids measurement, you cannot collect it later

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Four months on the site and I was confusing area% and mass% in every post I made. One explainer thread and it clicked.

That is net peptide content, not purity. Different number, different meaning.